In vivo modulation of FGF biological activity alters cranial suture fate
about
Mechanical influences on suture development and patencySignaling mechanisms implicated in cranial sutures pathophysiology: CraniosynostosisCraniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndromeHigh-dose retinoic acid modulates rat calvarial osteoblast biology.Distribution of fibroblast growth factors (FGFR-1 and -3) and platelet-derived growth factor receptors (PDGFR) in the rat mandibular condyle during growth.Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion.Paracrine interaction between adipose-derived stromal cells and cranial suture-derived mesenchymal cells.The BMP antagonist noggin regulates cranial suture fusion.Effects of thyroxine exposure on osteogenesis in mouse calvarial pre-osteoblasts.New therapeutic targets in rare genetic skeletal diseases.Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice.Differential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells in vitro.The role of vertebrate models in understanding craniosynostosis.Craniofacial surgery, from past pioneers to future promise.Models of cranial suture biology.Craniosynostosis: molecular pathways and future pharmacologic therapy.A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.BCL11B regulates sutural patency in the mouse craniofacial skeleton.Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells.Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor.Noggin inhibits postoperative resynostosis in craniosynostotic rabbits.Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse modelCraniosynostosis, psychomotor retardation, and facial dysmorphic features in a Spanish patient with a 4q27q28.3 deletionRelaxin does not rescue coronal suture fusion in craniosynostotic rabbitsGenetic basis of potential therapeutic strategies for craniosynostosis
P2860
Q24644627-109F687B-5E6F-47F9-A898-D1B095C481F7Q28073737-0DE0BF58-48B6-42E5-9170-C0164AB6CC6AQ28509010-8FED952B-010A-4F74-B5C3-1D813E8062F8Q29465464-B8EC8A1A-BB86-42ED-9199-566C864BFAE4Q30844773-14E2FDE8-ECAF-4D79-AB3B-2F6E1315C168Q33505673-B1E99158-A152-49C3-B3E7-5BF58B8F6EF9Q34106331-5AF1CAD8-8FBD-48BE-BFFF-A7CFECB918FDQ34189687-5477A923-8626-494B-8372-20E98B629E5AQ34919063-F5A93CAE-2182-4E63-92C1-D5FD0BE555B8Q36275329-C7142738-046F-42C7-9458-44AFF00B1840Q36800176-9F987B97-63E6-44EA-92B9-9C8517958B3EQ37357714-A6B913CD-1804-40D4-AC6E-9E37EDD17602Q38032780-1622C216-585F-4EBF-A68E-8E533B0AE7FCQ38058778-990D4279-B32F-427B-8636-0BF06D64D579Q38060056-6DCD47A4-DAE5-44B8-A00A-5B5C2A5DD668Q38068256-0E12E3A3-1F50-4883-AFD0-74C06C58A3F9Q39692110-8D870255-0C91-45EC-984D-D8F321BFD3E2Q39821666-3358647B-FE8A-4CF0-B03C-426A6062A2C6Q40006898-C437AFD9-B925-46A1-A9A7-73EB3B683FF4Q40867214-78BA7B2B-B605-42C5-804F-9BCA3E08F7C6Q44846203-1ADE0317-59E7-4703-8339-BBFE39FE5DCCQ48201310-B5F59BC4-4405-4187-860B-FE17585F7773Q56262145-A129B4E2-EF88-4C88-8DF4-00E38FE1BB29Q56266838-6157D6E9-9E4D-4D92-A75F-9DEB25DDC3CFQ56320820-B7E7DCD1-98DD-4E75-BCA8-7BFCAB12B25BQ56330928-21054C69-348A-40B7-A995-63DA7AA7B011
P2860
In vivo modulation of FGF biological activity alters cranial suture fate
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
In vivo modulation of FGF biological activity alters cranial suture fate
@ast
In vivo modulation of FGF biological activity alters cranial suture fate
@en
type
label
In vivo modulation of FGF biological activity alters cranial suture fate
@ast
In vivo modulation of FGF biological activity alters cranial suture fate
@en
prefLabel
In vivo modulation of FGF biological activity alters cranial suture fate
@ast
In vivo modulation of FGF biological activity alters cranial suture fate
@en
P2093
P2860
P1476
In vivo modulation of FGF biological activity alters cranial suture fate
@en
P2093
B J Mehrara
F E Crisera
J A Greenwald
J A Spector
M T Longaker
P J Bouletreau
P J Fagenholz
S M Warren
P2860
P304
P356
10.1016/S0002-9440(10)63987-9
P407
P577
2001-02-01T00:00:00Z